Abbott Laboratories (ABT)

Acerca de Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

Al 3 de noviembre de 2026, la acción de Abbott Laboratories (ABT) bajó a $109.61, una baja de 0.50% (-$0.55) frente al cierre anterior. En la sesión, las acciones han operado entre $109.09 y $110.60. Eso ubica a ABT cerca de la mitad de su rango de 52 semanas, de $81.97 a $132.03. Abbott Laboratories opera en el sector de pharmaceutical preparations y tiene una capitalización de mercado de aproximadamente $190.62 mil millones, con cerca de 767.8 mil acciones negociadas.

Últimas noticias de ABT

• Biosensors - Global Strategic Business Report: Secure Share of the $53.7 Billion Market by 2030 as Abbott, Dexcom, Medtronic and Masimo Accelerate Wearable and AI DiagnosticsYahoo Finance· 3 nov, 9:41 a.m. ETCAGR
• Is BSX Worth Buying Now as Low Valuation Meets Weak Earnings Growth?Yahoo Finance· 3 nov, 8:21 a.m. ET
• Spinal cord stimulator lawsuits surge: what is going wrong?medicaldevice-network.com· 3 nov, 7:52 a.m. ET
• Why Did Boston Scientific Stock Jump?trefis.com· 3 nov, 7:41 a.m. ET
• BridgeBio to Present New Acoramidis Data on Heart Failure Events in ATTR-CM at the American Heart Association Scientific Sessions 2026Yahoo Finance· 3 nov, 7:30 a.m. ET
• Abbott’s Amulet 360 demonstrates strong one-year outcomes in AFib patientsclinicaltrialsarena.com· 3 nov, 7:25 a.m. ETLAA
• What Are Danaher Investors Betting On?trefis.com· 3 nov, 6:56 a.m. ET
• Should Retail Leadership Reset Require Action From Marzetti (MZTI) Investors?Yahoo Finance· 2 nov, 7:17 p.m. ETMZTI

Fuente: Yahoo Finance RSS · Actualizado el 3 de noviembre de 2026

¿Quieres titulares, alertas e investigación con IA de ABT en un solo lugar? Crea una cuenta gratis →

• added $ABT Nov 11/117 call spreads

  @harmongreg· 2 nov, 3:45 p.m. ET

• $ABT great run for us - we remain on track for $120+ in the coming weeks 🥂

  @DBRGLong· 2 nov, 3:38 p.m. ET· Alcista

• $ABT: it's moving day. We in calls in the Live Options Room from last week. Safe haven play.

  @Dr_Stoxx· 2 nov, 10:03 a.m. ET

• $ABT Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System "SonicForce is an investigational coronary intravascular lithotripsy (IVL) system that u…

  @AlertsAndNews· 1 nov, 5:56 p.m. ET

• $ABT 🏥 Abbott Laboratories reported strong 30-day outcomes and high procedural success from the TECTONIC clinical trial of its investigational SonicForce Coronary Intravascular Lithotripsy System for treating coronary calcium. Selected from hundreds of headlines

  @Rayvio_News_Filter· 1 nov, 3:45 p.m. ET

Fuente: Stocktwits. Las publicaciones de usuarios son opiniones, no hechos verificados. Ver lo que es tendencia →